- Home
- ARQT vs PAGP Comparison
ARQT vs PAGP Comparison
Compare ARQT & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARQT | PAGP |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.8B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ARQT | PAGP |
|---|---|---|
| Price | $28.22 | $19.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | ★ $24.83 | $20.17 |
| AVG Volume (30 Days) | ★ 1.7M | 1.6M |
| Earning Date | 02-24-2026 | 02-06-2026 |
| Dividend Yield | N/A | ★ 7.75% |
| EPS Growth | N/A | ★ 11.94 |
| EPS | N/A | ★ 0.95 |
| Revenue | $317,929,000.00 | ★ $46,917,000,000.00 |
| Revenue This Year | $85.51 | N/A |
| Revenue Next Year | $30.74 | $7.33 |
| P/E Ratio | ★ N/A | $20.74 |
| Revenue Growth | ★ 129.21 | N/A |
| 52 Week Low | $11.13 | $16.61 |
| 52 Week High | $31.77 | $22.31 |
Technical Indicators
Market Signals| Indicator | ARQT | PAGP |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 69.92 |
| Support Level | $28.75 | $19.16 |
| Resistance Level | $30.60 | $19.73 |
| Average True Range (ATR) | 1.31 | 0.28 |
| MACD | -0.14 | 0.05 |
| Stochastic Oscillator | 15.13 | 96.98 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests
Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.